Selected Presentations by Nancy Patterson
Nancy Patterson
A much sought after speaker in the area of valuation and lifescience investment. Ms. Patterson is frequently invited to lecture on how to determine the probability of successful commercialization of an emerging technology which she does using a proprietary 12 weighted driver method. A few example topics of presentations include:
- What level of successful commercialization is anticipated for a pre-clinical changing the standard of care technology?
- I have an innovative platform technology, with four or five potential indications for use. How do I determine which indication should be our beachhead indication? I need a rigorous process to make this determination.
- How do I ensure that investors will grasp the value my technology and agree to a reasonable valuation?
- How much is my preclinical innovation worth? How can I prove it?
- Weighting the 12 drivers of successful commercialization for an innovative medical device, and how it affects the value of an emerging technology?
Since 2006 through 2014 Ms. Patterson was a guest speaker each quarter at the UCLA medical school core class entitled The Business of Science. This graduate school class, one of the most popular in the medical school, teaches about the path to successful commercialization for lifescience technology.
Learn more about Nancy Patterson and invite her to give a lecture for your group.
Selected Presentations
University of California at Los Angeles, CA, April 18, 2012, Business of Science Title: Ensuring Successful Commercialization of Emerging Lifescience Technologies Los Angeles, CA
Clinical and Translational Science Institute (CTSI), Perkins Coie Venture Team $30,000 Competition, Moderator and Industry Mentor, June 4, 2012, University of California at Los Angeles, CA
University of California at Los Angeles, CA, November 16, 2011, Business of Science, Title: Securing Investments for Your Compelling Lifescience Technology, Los Angeles, CA
University of California at Los Angeles, CA, October 26, 2011, Business of Science Title: Valuing Emerging Technologies: Early Stage Technologies – How to Determine What They Are Worth, Los Angeles, CA
WARF, University of Wisconsin Technology Transfer, July 26, 2011, Title: TechSelect: Identification and Prioritization of Emerging Lifescience Technology with the Highest Probability of Successful Commercialization, Webinar
University of California at Los Angeles, CA, April 27, 2011, Business of Science, Title: Successful Commercialization of Emerging LifeScience Technologies, Los Angeles, CA
Harbor UCLA – LA BioMed, March 1, 2011, Identification and Prioritization of Emerging Lifescience Technology with the Highest Probability of Successful Commercialization: Results of a 6 Month Study, Torrance, CA
University of California at Los Angeles, CA, December 1, 2010, Business of Science Title: Successful Commercialization of Emerging LifeScience Technologies Los Angeles, CA
IESE Business School, University of Navarra, November 3, 2010 Title: Entrepreneurship and Innovation in Life Science Technology in 2020Global Meeting of the Health-Care Industry, The Health-care Industry in 2020, Barcelona Spain
Caltech (California Institute of Technology), May 26, 2010, The Biotech Club Industry Night, Keynote Speech, Biotechnology: Title: The Direction of Investments in Biotechnology Innovation, Pasadena, CA
University of California at Los Angeles, CA, April 28, 2010, Business of Science, Title: Successful Commercialization of Emerging LifeScience Technologies Los Angeles, CA
JointVentures, November 9, 2010, Moderator, Title: Healthcare Reform and its Impact on Ortho/Spine, Grant Hyatt, San Francisco, CA
Webinar: Elsevier Medtech Insight IN3 Webinar Series, December 11, 2009, Title: Avoiding the 14 Biggest Mistakes Made By Emerging Lifescience Companies
Elsevier Medtech Insight Medical Device Investor Forum / IN3 East, Westin Copley Plaza, Boston, MA, June 23, 2009, Title: Setting the Right Trajectory: Avoiding the 14 Biggest Mistakes Made By Emerging Lifescience Companies
University of California at Los Angeles, CA, April 9, 2009, Business of Science, Title: Hot Emerging Biomedical Technologies and Their Successful Commercialization, Los Angeles, CA
Stanford University, Management Science and Engineering 256, May 22, 2009, Title: Early Stage Technology Assessment
Hospital Clínic de Barcelona (Dr. Joan Bigorra and LIM Global), December 9, 2008, Title: What’s Hot and What’s Not in Biomedical Technology, Barcelona, Spain
Technion University, December 4, 2008, Title: Exit Strategies for Lifescience Technologies: Determining the Path to Obtain Maximum Value, Haifa, Israel
Biomedical Engineering Society, AIMBE invited presenter, October 3, 2008, Title: AIMBE Public Policy session – Translational BME, St. Louis, MO
University of California at Los Angeles, October. 30, 2008, Business of Science, Title: Presenting Your Compelling Lifescience Technology, Los Angeles, CA,
University of California at Los Angeles, May 30, 2008, Business of Science, Title: Developing a Business Plan for Increased Valuation, Los Angeles, CA
University of California at San Diego, January 14, 2008, Biomedical Engineering, Title: Presenting Your Lifescience Technology: Template for Success, San Diego, CA
Invited presenter, Licensing Executives Society, November 2007, Title: Emerging Biomedical Technologies: Landscape for Successful Technology Selection, Los Angeles, CA
Keynote Speaker, National Academies Round Table, July 17, 2007, Biomedical Engineering Materials and Applications, Title: Surgical Sealants and Tissue Adhesives, Woods Hole, MA
California Institute of Technology, May 2, 2007, Title: Emerging Life Science Technology: From Concept to Reality, Pasadena, California
Invited Speaker, Licensing Executives Society Annual Meeting, February 21, 2007, Title: Emerging Biomedical Technology: What’s Hot and What’s NOT, San Francisco, CA
Stanford University, Kauffman Global Scholars, February 22, 2007, Title: Emerging Lifescience Technology and Successful Commercialization, Palo Alto, CA
University of Washington, Biomedical Engineering, January 20, 2007, Title: Presenting Your Lifescience Technology: Template for Success, Seattle, WA
Keynote speaker, BME Idea, Biomedical Engineering Society Annual Conference, October 11, 2006, Chicago, IL, Title: “Concepts for Commercialization”;
Nancy Patterson, “Emerging Biomedical Technologies: What’s Hot and What’s Not”, Los Angeles Chapter of Licensing Executive Society, March 23, 2006
Invited presenter, Licensing Executives Society, February 19, 2006, Title: Emerging Biomedical Technologies: Landscape for Successful Technology Selection, Irvine, CA
Nancy Patterson, “Hot Emerging Biomedical Technologies and Their Successful Commercialization”, Buena Ventura Chapter of IEEE Engineering and Medicine in Biology Society, March 30, 2005
Course developer and Key Presenter, University of California at Irvine, January 13, 2005 – January 27, 2005, Title: Securing Venture Capital Funding for Your Medical Device, Irvine, CA
Nancy Patterson, “Securing Venture Capital Funding for your Medical Device”, University of California, Irvine, 2005
Nancy Patterson, “Securing Venture Capital Funding for your Medical Device”, University of California, Irvine, 2004